Christopher M. Smith - 15 Aug 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Aug 2022, 19:13:39 UTC
Prior SEC filing
27 Jun 2022
Next SEC filing
15 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ali Olivo, Attorney-in-Fact

Key filing fact

Christopher M. Smith filed Form 4 for NEOGENOMICS INC (NEO) on 17 Aug 2022.

Key facts

  • This page summarizes Christopher M. Smith's Form 4 filing for NEOGENOMICS INC (NEO).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Aug 2022, 19:13.

Change

  • Previous filing in this sequence was filed on 27 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEO transaction

Common Stock

Award

Transaction value
$0
Shares
+336,767
Change %
Price
$0.000000
Shares after
336,767
Date
15 Aug 2022
Ownership
Direct
Footnotes
F1
NEO transaction

Common Stock

Award

Transaction value
$0
Shares
+265,452
Change %
+79%
Price
$0.000000
Shares after
602,219
Date
15 Aug 2022
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+694,444
Change %
Price
$0.000000
Shares after
694,444
Date
15 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
694,444
Exercise price
$12.62
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On August 15, 2022, Mr. Smith was granted 336,767 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.

Footnote F2

On August 15, 2022, Mr. Smith was granted 265,452 restricted stock awards. These awards vest on the fourth anniversary date of the grant date.

Footnote F3

On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .